EE Impact

Daewoong Pharmaceutical

South Korea · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products.

Status last verified 03/08/2026Source checked 25/04/2025Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 18/04/2025 · Reference ↗

On April 18, 2025 Daewoong announced that it has filed for marketing authorization for Enblo in six Latin American countries, including Costa Rica, Honduras, the Dominican Republic, Panama, El Salvador, and Guatemala, as well as in Russia.

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.